Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2009 1
2010 3
2011 3
2012 3
2013 2
2014 4
2015 4
2016 5
2017 9
2018 10
2019 5
2020 6
2021 2
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Reply by Authors.
Doan P, Scheltema MJ, Amin A, Shnier R, Geboers B, Gondoputro W, Moses D, van Leeuwen PJ, Haynes AM, Matthews J, Brenner P, O'Neill G, Yuen C, Delprado W, Stricker P, Thompson J. Doan P, et al. Among authors: haynes am. J Urol. 2022 Nov;208(5):1036. doi: 10.1097/JU.0000000000002885.02. Epub 2022 Sep 12. J Urol. 2022. PMID: 36094874 No abstract available.
African-specific molecular taxonomy of prostate cancer.
Jaratlerdsiri W, Jiang J, Gong T, Patrick SM, Willet C, Chew T, Lyons RJ, Haynes AM, Pasqualim G, Louw M, Kench JG, Campbell R, Horvath LG, Chan EKF, Wedge DC, Sadsad R, Brum IS, Mutambirwa SBA, Stricker PD, Bornman MSR, Hayes VM. Jaratlerdsiri W, et al. Among authors: haynes am. Nature. 2022 Sep;609(7927):552-559. doi: 10.1038/s41586-022-05154-6. Epub 2022 Aug 31. Nature. 2022. PMID: 36045292 Free PMC article.
Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
Vis AN, Meijer D, Roberts MJ, Siriwardana AR, Morton A, Yaxley JW, Samaratunga H, Emmett L, van de Ven PM, Heymans MW, Nieuwenhuijzen JA, van der Poel HG, Donswijk ML, Boellaard TN, Schoots IG, Stricker P, Haynes AM, Oprea-Lager DE, Coughlin GD, van Leeuwen PJ. Vis AN, et al. Among authors: haynes am. Eur Urol Oncol. 2023 Dec;6(6):553-563. doi: 10.1016/j.euo.2023.03.010. Epub 2023 Apr 10. Eur Urol Oncol. 2023. PMID: 37045707 Free article.
Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers.
Gong T, Jaratlerdsiri W, Jiang J, Willet C, Chew T, Patrick SM, Lyons RJ, Haynes AM, Pasqualim G, Brum IS, Stricker PD, Mutambirwa SBA, Sadsad R, Papenfuss AT, Bornman RMS, Chan EKF, Hayes VM. Gong T, et al. Among authors: haynes am. Genome Med. 2022 Aug 31;14(1):100. doi: 10.1186/s13073-022-01096-w. Genome Med. 2022. PMID: 36045381 Free PMC article.
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.
Doan P, Scheltema MJ, Amin A, Shnier R, Geboers B, Gondoputro W, Moses D, van Leeuwen PJ, Haynes AM, Matthews J, Brenner P, O'Neill G, Yuen C, Delprado W, Stricker P, Thompson J. Doan P, et al. Among authors: haynes am. J Urol. 2022 Nov;208(5):1028-1036. doi: 10.1097/JU.0000000000002885. Epub 2022 Aug 10. J Urol. 2022. PMID: 35947521 Clinical Trial.
Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.
Geboers B, Gondoputro W, Thompson JE, Reesink DJ, van Riel LAMJG, Zhang D, Blazevski A, Doan P, Agrawal S, Matthews J, Haynes AM, Liu Z, Delprado W, Shnier R, de Reijke TM, Lawrentschuk N, Stijns PEF, Yaxley JW, Scheltema MJ, Stricker PD. Geboers B, et al. Among authors: haynes am. Eur Urol Focus. 2022 Nov;8(6):1591-1598. doi: 10.1016/j.euf.2022.04.010. Epub 2022 May 14. Eur Urol Focus. 2022. PMID: 35577751
58 results